GGrantIndex
← Leaderboards

Thomas Spurgeon Wingo

Emory University

$12,227,212
Attributed
$23,010,196
Total exposure
12
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.5M · FY201425
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,010,196 · 11
VA$0 · 1

By mechanism

R01$13,448,063 · 4
U01$4,511,944 · 1
R56$2,287,223 · 3
P30$1,777,919 · 2
P50$985,047 · 1
IK2$0 · 1

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseBrainGeneticS Disease RiskDementiaInsightAffectGenesProteomicsProteinsBiologicalBaseParticipantBrain TissueMolecularAutopsyMental DepressionGenetic VariantCognitiveData SetProteomePublic HealthCohort

Grant awards (39)

IMPACT-ADRD: Investigating the Multi-omics Perturbations Associated with Complex Environmental Toxicants and their Contribution to Alzheimer's Disease and Related Dementias$2,133,773
U01 · FY2025 · AG
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease$756,545
R01 · FY2025 · AG · contact PI
Air pollution and early signs of dementia$738,002
R01 · FY2025 · AG
The brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia$726,571
R01 · FY2025 · AG
IMPACT-ADRD: Investigating the Multi-omics Perturbations Associated with Complex Environmental Toxicants and their Contribution to Alzheimer's Disease and Related Dementias$99,867
U01 · FY2025 · AG
IMPACT-ADRD: Investigating the Multi-omics Perturbations Associated with Complex Environmental Toxicants and their Contribution to Alzheimer's Disease and Related Dementias$2,278,304
U01 · FY2024 · AG
The brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia$818,612
R01 · FY2024 · AG
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease$750,835
R01 · FY2024 · AG · contact PI
Air pollution and early signs of dementia$696,838
R01 · FY2024 · AG
A brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia$1,004,592
R01 · FY2023 · AG
Air pollution and early signs of dementia$760,906
R01 · FY2023 · AG
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease$750,835
R01 · FY2023 · AG · contact PI
Emory Alzheimer's Disease Research Center$379,751
P30 · FY2023 · AG · contact PI
A brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia$808,578
R01 · FY2022 · AG
Air pollution and early signs of dementia$763,967
R01 · FY2022 · AG
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease$763,880
R01 · FY2022 · AG · contact PI
Emory Alzheimer's Disease Research Center$421,838
P30 · FY2022 · AG · contact PI
A brain multi-omic approach to identify key molecular drivers of neuropsychiatric$226,909
R01 · FY2022 · AG
Understanding the molecular mechanisms of Depression and Psychological Well-being in Alzheimer's disease$730,037
R01 · FY2021 · AG · contact PI
Emory Alzheimer's Disease Research Center$438,674
P30 · FY2021 · AG · contact PI
Understanding the molecular mechanisms of Depression and Psychological Well-being in Alzheimer's disease$799,093
R01 · FY2020 · AG · contact PI
Emory Alzheimer's Disease Research Center$537,656
P30 · FY2020 · AG · contact PI
Understanding the molecular mechanisms of Depression and Psychological Well-being in Alzheimer's disease$36,403
R01 · FY2020 · AG · contact PI
Understanding the molecular mechanisms of Depression and Psychological Well-being in Alzheimer's disease$754,002
R01 · FY2019 · AG · contact PI
Elucidating the Role of Plasma Cholesterol in Alzheimer's Disease using Mendelian Randomization$710,738
R56 · FY2019 · AG · contact PI
A Proteogenomic Approach to Understanding AD GWAS Results$233,451
P50 · FY2019 · AG · contact PI
Computational Prediction and Functional Validation of Novel Epigenetic Risk Loci in Alzheimer's Disease$788,285
R56 · FY2018 · AG
Computational Prediction and Functional Validation of Novel Risk Loci of Alzheimer's Disease$788,200
R56 · FY2018 · AG
Understanding the molecular mechanisms of Depression and Psychological Well-being in Alzheimer's disease$764,758
R01 · FY2018 · AG · contact PI
A Proteogenomic Approach to Understanding AD GWAS Results$238,093
P50 · FY2018 · AG · contact PI
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease$0
IK2 · FY2018 · VA · contact PI
Understanding the molecular mechanisms of Depression and Psychological Well-being in Alzheimer's disease$796,700
R01 · FY2017 · AG · contact PI
A Proteogenomic Approach to Understanding AD GWAS Results$175,157
P50 · FY2017 · AG · contact PI
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease$0
IK2 · FY2017 · VA · contact PI
A Proteogenomic Approach to Understanding AD GWAS Results$170,008
P50 · FY2016 · AG · contact PI
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease$0
IK2 · FY2016 · VA · contact PI
A Proteogenomic Approach to Understanding AD GWAS Results$168,338
P50 · FY2015 · AG · contact PI
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease$0
IK2 · FY2015 · VA · contact PI
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease$0
IK2 · FY2014 · VA · contact PI